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Abstract
Five methods were compared, using conventional PCR, for the
isolation of DNA from Aspergillus fumigatus conidia from 1–3-mL
samples of whole blood. A lower detection threshold of Asper-
gillus conidia was achieved using 3-mL rather than 1-mL samples
with three of ﬁve methods tested.
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Invasive fungal infections are increasing in immunocompro-
mised individuals and Aspergillus fumigatus is one of the most
important fungal pathogens that endanger this group of
patients. The detection of fungal DNA in blood or other
clinical material via PCR is highly sensitive and has been fre-
quently studied [1–5]. The initial problem is the extraction
of fungal DNA from clinical specimens. Despite many efforts
to ﬁnd an appropriate and sensitive method, there is no
agreement about an optimal procedure for the extraction
of A. fumigatus DNA from whole blood [6–9]. In addition,
to date, no study investigating the effect of different sample
volumes on the efﬁciency of DNA extraction from blood
samples has been carried out.
In the present study, we have analysed this effect on the
extraction of A. fumigatus DNA using ﬁve different methods
with two different sample volumes.
Methods include different techniques, such as a phenol–
chloroform extraction and three commercially available kits:
the Invisorb Spin Plant Mini kit (Invitek, Berlin, Germany),
the FastDNA kit (MP Biomedicals, Heidelberg, Germany) and
the High Pure PCR template preparation kit (Roche, Mann-
heim, Germany), with the latter kit using with two different
pre-treatment steps.
Suspensions of A. fumigatus (DSM 790) conidia were pre-
pared from fresh A. fumigatus colonies cultured on Sabouraud
dextrose agar plates (Becton & Dickinson, Heidelberg, Ger-
many) as described previously [10]. Dilutions were prepared
by diluting the original suspension serially 1:10 with sterile sal-
ine and checked by plating on Sabouraud dextrose agar. For
sample preparation, whole blood was drawn from a healthy
volunteer and spiked with A. fumigatus conidia yielding ﬁnal
concentrations of 1 · 105 to 1 CFU/mL, respectively. The
blood samples were divided into 5 · 1 mL and 5 · 3 mL,
respectively. Hypotonic lysis of erythrocytes and enzymatic
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lysis of leukocytes was performed as reported previously [6].
Samples processed by three methods were treated with lyti-
case: DNA extraction using phenol–chloroform, Invisorb Spin
Plant Mini kit and High Pure PCR template preparation kit.
Samples were centrifuged, the pellet resuspended in 50 mM
NaOH and incubated at 95C for 10 min. After centrifuga-
tion, the pellet was resuspended in 500 lL of lyticase solution
(50 mM Tris (pH 7.6), 10 mM EDTA, 28 mM mercaptoetha-
nol, 0.3 mg/L recombinant lyticase (MP Biomedicals)) and
incubated for 30 min at 37C. After an additional centrifuga-
tion step, the Invisorb kit and the High Pure kit were used in
accordance with the manufacturer’s instructions.
In addition, the High Pure kit was evaluated in combina-
tion with glass bead-beating. The EWCLB-treated sample
was transferred into a new tube containing approximately
60–70 mg of glass beads (acid-washed, 710–1180 lm; Sigma,
Steinheim, Germany).
The suspension was vortexed for 10 s and transferred
into a new tube. After centrifugation, the supernatant was
discarded and the sample treated according to the manufac-
turer’s instructions.
For extraction using the FastDNA kit, samples were cen-
trifuged after WCLB-incubation and 1.2 mL of the superna-
tant transferred into FastDNA tubes containing Lysing
Matrix A (garnet matrix and one ¼ inch ceramic sphere).
Cells were disrupted using the Fast Prep FP120 cell disrupter
(Qbiogene, Illkirch, France) at 5.5 m/s for 30 s. Treatment
was repeated twice and samples processed according to
manufacturer’s instructions.
Samples extracted with phenol–chloroform were treated
as described previously [11].
Negative controls were included in each extraction
method to detect contaminations extracted DNA was ampli-
ﬁed by PCR using a primer set for the fungal 18S rRNA mul-
ticopy gene which does not cross-hybridize with human
DNA [1]. The primer sequences were: 5¢-ATTggAggg
CAAgTCTggTg and 5¢-CCgATCCCTAgTCggCATAg. PCR
was performed in a volume of 55 lL, including 4 lL of nucle-
otides (Roche), 2 lL of 25 mM MgCl2, 5 · PCR buffer, 1 lL
of each primer (20 lM; TIB Molbiol, Berlin, Germany),
0.25 lL of Taq polymerase (1 U/lL; Applied Biosystems,
Branchburg, NJ, USA) and 7 lL of template DNA.
PCR conditions were set as described previously [1]. PCR
products were visualized on a 1.2% agarose gel. The results
were conﬁrmed in an independent experiment using PCR–
ELISA (data not shown).
The ﬁve different extraction methods yielded rather differ-
ent results revealing the importance of the technique chosen
for extraction (Table 1). All commercially available kits used
for this study achieved a higher sensitivity than the conven-
tional method with phenol–chloroform. Additionally, the
processing time was shorter (up to 7 h) if a kit was used.
The phenol–chloroform extraction showed the lowest sensi-
tivity for detection of Aspergillus DNA independent of vol-
ume size, followed by the Invisorb kit. The sample volume
was crucial for all methods tested except the High Pure kit
when used with glass bead-beating. This method showed the
same detection limit for both volumes, each recovering
(a)
(b)
+ 3 ng
1 mL
3 mL
1 mL
3 mL
300 pg 30 pg 3 pg 300 fg 30 fg
FIG. 1. Gel electrophoresis of samples extra-
cted by High Pure PCR template preparation
kit. Sample volumes of 3 and 1 mL were com-
pared in combination with (a) cell wall disrup-
tion using glass beads and (b) treatment with
lyticase. +, Positive control.
TABLE 1. Summary of detection
cut-offs of Aspergillus fumigatus
conidia in whole blood extracted
using the indicated methods, and
their duration
Extraction method Costs/sample (€) Duration (h)
Detection cut-off
(CFU/mL)
1 mL 3 mL
Phenol–chloroform 0.50 10 104 104
Invisorb Spin Plant Mini kit 3.00 3 104 103
FastDNA kit 3.20 3 103 101
High Pure kit/lyticase 2.70 5 103 101
High Pure kit/glass beads 2.20 4 1 1
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approximately 30 fg of DNA, which corresponds to 1 CFU/
mL [12]. All other methods proved to be more sensitive
with sample sizes of 3 mL rather than 1 mL. The FastDNA
kit and the High Pure kit in combination with lyticase
allowed detectection of approximately 300 fg of DNA if a
volume of 3 mL whole blood was used. By contrast, a samp-
le volume of 1 mL achieved a detection cut-off of 3 pg,
which comprises a difference of 2 log units showing a 100-
fold decline in sensitivity (Fig. 1).
These results showed that an initial sample volume of
3 mL yielded a higher sensitivity compared to a 1-mL sam-
ple volume. Hence, 3 mL should be the preferred volume.
In addition, bead-beating was more efﬁcient in disrupting
the fungal cell walls than lyticase (Fig. 1) and a sample vol-
ume of 3 mL may be reduced to 1 mL with similar sensitiv-
ity in the case of the High Pure kit with bead-beating
[7,13,14]. Other potential advantages of the treatment with
glass beads are the saving of time and costs compared to
the enzymatic lysis (Table 1). However, in terms of clinical
relevance, the results should be interpreted with caution.
Clinical specimens might behave differently than spiked
blood obtained from a healthy volunteer. Additionally, there
is a lack of clarity regarding the ideal specimen type. Whole
blood was used in the present study because it is easy to
obtain and the risk of contamination is relatively low in
contrast to material such as bronchoalveolar lavage ﬂuid.
Nevertheless, further studies should be performed using
bronchoalveolar lavage ﬂuid, serum or plasma to conﬁrm
the existing ﬁndings.
Transparency Declaration
The authors declare that they have no conﬂicts of interest in
relation to this work.
References
1. Einsele H, Hebart H, Roller G et al. Detection and identiﬁcation of
fungal pathogens in blood by using molecular probes. J Clin Microbiol
1997; 35: 1353–1360.
2. Skladny H, Buchheidt D, Baust C et al. Speciﬁc detection of Aspergillus
species in blood and bronchoalveolar lavage samples of immunocompro-
mised patients by two-step PCR. J Clin Microbiol 1999; 37: 3865–3871.
3. Hebart H, Lo¨fﬂer J, Meisner C et al. Early detection of aspergillus
infection after allogeneic stem cell transplantation by polymerase
chain reaction screening. J Infect Dis 2000; 181: 1713–1719.
4. Pryce TM, Kay ID, Palladino S, Heath CH. Real-time automated poly-
merase chain reaction (PCR) to detect Candida albicans and Aspergillus
fumigatus DNA in whole blood from high-risk patients. Diagn Micro-
biol Infect Dis 2003; 47: 487–496.
5. Buchheidt D, Baust C, Skladny H et al. Detection of Aspergillus spe-
cies in blood and bronchoalveolar lavage samples from immunocom-
promised patients by means of 2-step polymerase chain reaction:
clinical results. Clin Infect Dis 2001; 33: 428–435.
6. Lo¨fﬂer J, Hebart H, Schumacher U, Reitze H, Einsele H. Comparison
of different methods for extraction of DNA of fungal pathogens from
cultures and blood. J Clin Microbiol 1997; 35: 3311–3312.
7. van Burik JA, Schreckhise RW, White TC, Bowden RA, Myerson D.
Comparison of six extraction techniques for isolation of DNA from
ﬁlamentous fungi. Med Mycol 1998; 36: 299–303.
8. Grifﬁths LJ, Anyim M, Doffman SR, Wilks M, Millar MR, Agrawal
SG. Comparison of DNA extraction methods for Aspergillus
fumigatus using real-time PCR. J Med Microbiol 2006; 55: 1187–
1191.
9. Fredricks DN, Smith C, Meier A. Comparison of six DNA extraction
methods for recovery of fungal DNA as assessed by quantitative
PCR. J Clin Microbiol 2005; 43: 5122–5128.
10. Espinel-Ingroff A, Bartlett M, Chaturvedi V et al. Optimal susceptibil-
ity testing conditions for detection of azole resistance in Aspergillus
spp.: NCCLS collaborative evaluation. National Committee for Clini-
cal Laboratory Standards. Antimicrob Agents Chemother 2001; 45:
1828–1835.
11. Millon L, Manteaux A, Reboux G et al. Fluconazole-resistant recur-
rent oral candidiasis in human immunodeﬁciency virus-positive
patients: persistence of Candida albicans strains with the same geno-
type. J Clin Microbiol 1994; 32: 1115–1118.
12. Khot PD, Ko DL, Hackman RC, Fredricks DN. Development and
optimization of quantitative PCR for the diagnosis of invasive
aspergillosis with bronchoalveolar lavage ﬂuid. BMC Infect Dis 2008;
8: 73.
13. Haugland RA, Heckman JL, Wymer LJ. Evaluation of different
methods for the extraction of DNA from fungal conidia by quanti-
tative competitive PCR analysis. J Microbiol Methods 1999; 37: 165–
176.
14. Lo¨fﬂer J, Schmidt K, Hebart H, Schumacher U, Einsele H. Automated
extraction of genomic DNA from medically important yeast species
and ﬁlamentous fungi by using the MagNA Pure LC system. J Clin
Microbiol 2002; 40: 2240–2243.
688 Clinical Microbiology and Infection, Volume 15 Number 7, July 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 680–697
